National Planning Corporation’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-26,622
Closed -$745K 695
2016
Q2
$745K Sell
26,622
-260
-1% -$7.13K 0.06% 299
2016
Q1
$717K Sell
26,882
-1,704
-6% -$45.7K 0.06% 290
2015
Q4
$699K Sell
28,586
-2,842
-9% -$78.7K 0.06% 323
2015
Q3
$842K Buy
31,428
+996
+3% +$28.2K 0.08% 241
2015
Q2
$872K Sell
30,432
-1,998
-6% -$56.2K 0.08% 242
2015
Q1
$902K Sell
32,430
-5,040
-13% -$116K 0.08% 224
2014
Q4
$791K Sell
37,470
-6,542
-15% -$146K 0.06% 293
2014
Q3
$1.05M Sell
44,012
-6,038
-12% -$139K 0.08% 239
2014
Q2
$1.16M Buy
50,050
+400
+0.8% +$8.83K 0.09% 219
2014
Q1
$1.13M Buy
49,650
+19,120
+63% +$407K 0.1% 211
2013
Q4
$561K Buy
30,530
+1,240
+4% +$21.6K 0.05% 339
2013
Q3
$491K Buy
+29,290
New +$493K 0.05% 353

Other funds holding NVO

National Planning Corporation's NVO Position: Q3 2016 in Review

National Planning Corporation sold out of Novo Nordisk (NVO) in Q3 2016, closing a stake of 26,622 shares — an estimated $745K sold.

National Planning Corporation first reported a position in NVO in Q3 2013 and held it in 12 quarters. The position peaked at $1.16M in Q2 2014. 511 funds tracked by Wall St. Rank hold NVO as of Q3 2016.

  • National Planning Corporation reported no remaining Novo Nordisk position as of Q3 2016 after selling out during the quarter.
  • National Planning Corporation sold 26,622 Novo Nordisk shares in Q3 2016, an estimated $745K.
  • National Planning Corporation first reported a position in Novo Nordisk in Q3 2013 and held it in 12 quarters.
  • National Planning Corporation's Novo Nordisk position peaked at $1.16M in Q2 2014.
  • 511 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2016.

Based on National Planning Corporation's 13F filing for Q3 2016, filed 10 Nov 2016.